Showing all 11 results
Altretamine Capsules
FreeAltretamine capsules are antineoplastic (chemotherapy) medications used primarily for the palliative treatment of advanced ovarian cancer. They are most commonly available in a 50 mg strength.
Domperidone Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Rapid-Release / MD Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute chemical stability and instantaneous dissolution of the active ingredient.
Active Ingredient Strength Primary Clinical Function Domperidone Maleate USP/Ph.Eur. 10 mg The Global Antiemetic Standard: The definitive rapid-acting unit utilized globally for the immediate suppression of acute nausea and the acceleration of delayed gastric emptying. Excipients (MD Formulation) Microcrystalline Cellulose / Crospovidone / Mannitol / Aspartame / Peppermint Flavor / Magnesium Stearate Diluent / Superdisintegrant / Cooling Agent / Sweetener / Flavoring (Engineered specifically using elite “Rapid-Burst” superdisintegrants to ensure the Mouth Dissolving tablet shatters in saliva within seconds. This is critical because a vomiting patient physically cannot swallow water or a hard pill without instantly throwing it back up) *Pack Sizes: 10×10 Alu-Alu Blisters (Optimized specifically for strict, short-term gastrointestinal dispensing regimens).
Ethinyestradiol Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Hazard-Shielded Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-PVC or Alu-Alu blister strips to ensure the absolute chemical stability of the synthetic steroidal API.
Active Ingredient Strength Primary Clinical Function Ethinylestradiol USP/Ph.Eur. 0.05 mg (50 mcg) The Endocrinology Standard: The definitive micro-dose engineered specifically for female hypogonadism, primary ovarian failure, and strictly monitored estrogen replacement. Ethinylestradiol USP/Ph.Eur. 1 mg The Palliative Oncology Macrodose: Massive therapeutic payload utilized strictly for the aggressive hormonal suppression of advanced, inoperable prostate or breast cancer. Excipients Lactose Monohydrate / Microcrystalline Cellulose / Croscarmellose Sodium / Povidone K-30 / Magnesium Stearate / Premium Polymeric Film Diluent / Binder / Superdisintegrant / Lubricant / Heavy Film-Coating (Engineered specifically to form an impenetrable physical barrier over the tablet core. This completely seals the potent steroidal API, ensuring absolute safety for handlers and guaranteeing zero cross-contamination in the facility) *Pack Sizes: 10×10 Blisters or Bottles of 100 (Optimized specifically for strict chronic endocrine and oncology dispensing regimens).
Everolimus Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Antioxidant-Stabilized Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute chemical survival of the highly oxidative, potent API.
Active Ingredient Strength Primary Clinical Function Everolimus USP/Ph.Eur. 0.25 mg / 0.5 mg / 0.75 mg Global Transplant Standard: Ultra-micro doses utilized for strict, lifelong immunosuppression following renal or hepatic allografts. Requires extreme content uniformity to maintain the narrow therapeutic blood trough levels (3 to 8 ng/mL). Everolimus USP/Ph.Eur. 5 mg / 10 mg Global Oncology Standard: Massive-dose antineoplastic payload utilized for the aggressive suppression of Renal Cell Carcinoma, Neuroendocrine Tumors (NETs), and HR+/HER2- Breast Cancer. Excipients Butylated Hydroxytoluene (BHT) / Hypromellose / Lactose Anhydrous / Crospovidone / Magnesium Stearate Antioxidant / Binder / Diluent / Superdisintegrant / Lubricant (Engineered specifically utilizing BHT (Butylated Hydroxytoluene) to prevent the rapid oxidative degradation of the Everolimus molecule, guaranteeing maximum clinical shelf-life and potency across harsh climates) *Pack Sizes: 10×10 Alu-Alu Blisters (Transplant) or 3×10 Alu-Alu Blisters (Oncology – 30 Day Supply).
Nicotinamide Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Immediate-Release Tablet, packed exclusively in highly secure, moisture-resistant Alu-PVC or high-density HDPE bottles to ensure the absolute chemical stability of the highly soluble vitamin amide.
Active Ingredient Strength Primary Clinical Function Nicotinamide (Niacinamide) USP/Ph.Eur. 250 mg Dermatology / Acne Standard: Base therapeutic unit for the systemic reduction of inflammatory skin lesions and mild nutritional supplementation. Nicotinamide (Niacinamide) USP/Ph.Eur. 500 mg Oncology Prophylaxis / Pellagra Standard: High-dose adult therapy for non-melanoma skin cancer prevention and acute pellagra eradication. Excipients Microcrystalline Cellulose / Croscarmellose Sodium / Stearic Acid / Magnesium Stearate / Premium Opadry Film Diluent / Superdisintegrant / Lubricant (Engineered specifically for rapid, complete gastric dissolution to ensure peak systemic NAD+ saturation within 1 to 2 hours) *Pack Sizes: 10×10 Blisters or Bottles of 60/100 (Optimized specifically for chronic, twice-daily dermatological dispensing regimens).
Pazopanib Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Engineered, High-Density Film-Coated Tablet, packed exclusively in highly secure, child-resistant heavy-gauge HDPE bottles or specialized Alu-Alu blister strips to ensure the absolute chemical stability of the cytotoxic molecule and prevent accidental exposure.
Active Ingredient Strength Primary Clinical Function Pazopanib HCl INN/Ph.Eur. 200 mg (Base Equivalent) Dose-Modification Standard: Essential unit for precise dose reduction in patients experiencing severe hepatic toxicity or adverse drug reactions. Pazopanib HCl INN/Ph.Eur. 400 mg (Base Equivalent) Global Clinical Standard: Primary therapeutic unit designed to achieve the massive 800 mg daily protocol with minimal pill burden. Excipients Microcrystalline Cellulose / Sodium Starch Glycolate / Povidone K30 / Magnesium Stearate / Hypromellose / Titanium Dioxide Diluent / Superdisintegrant / Binder / Lubricant / Premium Cytotoxic-Barrier Film-Coating (Engineered specifically to seal the lethal HPAPI inside the tablet, completely protecting healthcare workers and caregivers from highly toxic dust exposure) *Pack Sizes: Bottles of 30 or 60 Tablets (Optimized specifically for strict 30-day chronic oncology dispensing regimens).
Sorafenib tablets 200mg
FreeA Sorafenib 200mg tablet is an oral multi-kinase inhibitor primarily containing Sorafenib as the active substance. It is used as a targeted therapy to treat advanced kidney cancer (renal cell carcinoma), liver cancer (hepatocellular carcinoma), and certain types of thyroid cancer.
Tamoxifen citrate Tablets
FreeA Tamoxifen citrate tablet is a selective estrogen receptor modulator (SERM) typically prescribed for the treatment and prevention of hormone receptor-positive breast cancer.
Tamoxifen Tablet
FreeA Tamoxifen tablet is a hormone-based medication used primarily to treat and prevent hormone receptor-positive breast cancer. It belongs to a class of drugs known as selective estrogen receptor modulators (SERMs)
Temozolamide tablets
FreeTemozolomide is primarily available as an oral capsule, though it is occasionally referred to as a “tablet” in some regions. It is a chemotherapy agent used to treat specific types of brain cancer, such as glioblastoma multiforme and anaplastic astrocytoma.
Temozolomide Capsules
FreeTemozolomide capsules are oral chemotherapy agents used primarily to treat specific types of brain tumours, such as glioblastoma multiforme and anaplastic astrocytoma. Because temozolomide is a hazardous drug, the capsules are designed to be swallowed whole to prevent direct exposure to the potent active ingredient.
